Evidence map›Paper›PMID 34843512›Full record

ArticlePloS one2021

Variant profiling of colorectal adenomas from three patients of two families with MSH3-related adenomatous polyposis.

Claudia Perne, Sophia Peters, Maria Cartolano, Sukanya Horpaopan, Christina Grimm, Janine Altmüller, Anna K Sommer, Axel M Hillmer, Holger Thiele, Margarete Odenthal and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Claudia PerneInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.
Sophia PetersInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.
Maria CartolanoDepartment of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Cologne, Germany.
Sukanya HorpaopanDepartment of Anatomy, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand.
Christina GrimmInstitute for Translational Epigenetics, Medical Faculty and University Clinic Cologne, University of Cologne, Cologne, Germany.
Janine AltmüllerCenter for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Anna K SommerInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.ORCID 0000-0001-6850-9290
Axel M HillmerInstitute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Holger ThieleCologne Center for Genomics (CCG), Faculty of Medicine, University of Cologne, University Hospital Cologne, Cologne, Germany.
Margarete OdenthalCenter for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Gabriela MösleinZentrum für Hereditäre Tumore, BETHESDA Khs. Duisburg, Duisburg, Germany.
Ronja AdamCancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Sugirthan SivalingamCore Unit for Bioinformatics Data Analysis, Medical Faculty, University of Bonn, Bonn, Germany.
Jutta KirfelInstitute of Pathology, University of Lübeck, Lübeck, Germany.
Michal R SchweigerCenter for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Martin PeiferDepartment of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Cologne, Germany.
Isabel SpierInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.
Stefan AretzInstitute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.ORCID 0000-0002-5228-1890
University of Cologne · DEUniversity of Bonn · DEAmsterdam University Medical Centers · NLNaresuan University · THUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spectrum of somatic genetic variation in colorectal adenomas caused by biallelic pathogenic germline variants in the MSH3 gene, was comprehensively analysed to characterise mutational signatures and identify potential driver genes and pathways of MSH3-related tumourigenesis. Three patients from two families with MSH3-associated polyposis were included. Whole exome sequencing of nine adenomas and matched normal tissue was performed. The amount of somatic variants in the MSH3-deficient adenomas and the pattern of single nucleotide variants (SNVs) was similar to sporadic adenomas, whereas the fraction of small insertions/deletions (indels) (21-42% of all small variants) was significantly higher. Interestingly, pathogenic somatic APC variants were found in all but one adenoma. The vast majority (12/13) of these were di-, tetra-, or penta-base pair (bp) deletions. The fraction of APC indels was significantly higher than that reported in patients with familial adenomatous polyposis (FAP) (p < 0.01) or in sporadic adenomas (p < 0.0001). In MSH3-deficient adenomas, the occurrence of APC indels in a repetitive sequence context was significantly higher than in FAP patients (p < 0.01). In addition, the MSH3-deficient adenomas harboured one to five (recurrent) somatic variants in 13 established or candidate driver genes for early colorectal carcinogenesis, including ACVR2A and ARID genes. Our data suggest that MSH3-related colorectal carcinogenesis seems to follow the classical APC-driven pathway. In line with the specific function of MSH3 in the mismatch repair (MMR) system, we identified a characteristic APC mutational pattern in MSH3-deficient adenomas, and confirmed further driver genes for colorectal tumourigenesis.

Indexed as

Activin Receptors, Type IIAdenomatous Polyposis ColiAdenomatous Polyposis Coli ProteinColorectal NeoplasmsHumansINDEL MutationMutS Homolog 3 ProteinPolymorphism, Single NucleotideActivin Receptors, Type IIactivin receptor type II-AAdenomatous Polyposis Coli ProteinAPC protein, humanMSH3 protein, humanMutS Homolog 3 Protein

Identifiers

PMID34843512
PMCPMC8629245
OpenAlexW3215535153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.